Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic| Chapter 8 | Perspective of Recent Advances in Medical Research Vol. 7

 The COVID-19 universal created it challenging to recognize and situation of Chronic Obstructive Pulmonary Disease (COPD) and raised death and morbidity. Treatment of COPD all along severe irritation requires aerosolization remedy like nebulization and non-obtrusive fresh air modalities like extreme-flow nasal hose (HFNC) and Non-obtrusive airing (NIV). Even though aerosolization therapy impacts the spread of COVID-19, accompanying decent carefulness COPD management has expected persisted as per standard approvals.

Author(s) Details:

Pratap Upadhya,
Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.

C. Sivaselvi,
Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.

Rohit Vadala,
All India Institute of Medical Sciences, New Delhi, India.

R. Manju,
Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.

Please see the link here: https://stm.bookpi.org/PRAMR-V7/article/view/9319